Losartan reduces the costs of diabetic end-stage renal disease: An Asian perspective
Author:
Publisher
Wiley
Subject
Nephrology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1797.2005.00472.x/fullpdf
Reference19 articles.
1. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies
2. The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan
3. End-Stage Renal Disease in the Asian-Pacific Region
4. 4. TO Lim, and YN Lim . Eleventh Report of the Malaysian Dialysis and Transplant Registry 2003. Kuala Lumpur: National Renal Registry, 2004 .
5. An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2002)+
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29
2. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia;International Journal of Environmental Research and Public Health;2020-08-07
3. Cost-Effectiveness Analysis of Renin-Angiotensin Aldosterone System Blockade in Progression of Chronic Kidney Disease;Value in Health Regional Issues;2018-05
4. Managing blood pressure control in Asian patients: safety and efficacy of losartan;Clinical Interventions in Aging;2014-03
5. Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review;BMC Nephrology;2014-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3